383 related articles for article (PubMed ID: 3512141)
1. Clinical pharmacokinetics of methoxsalen and other psoralens.
de Wolff FA; Thomas TV
Clin Pharmacokinet; 1986; 11(1):62-75. PubMed ID: 3512141
[TBL] [Abstract][Full Text] [Related]
2. Antipsoriatic, erythematogenic, and Langerhans cell marker depleting effect of bath-psoralens plus ultraviolet A treatment. Comparison of 8-methoxypsoralen and trimethylpsoralen photosensitization.
Koulu LM; Jansén CT
J Am Acad Dermatol; 1988 May; 18(5 Pt 1):1053-9. PubMed ID: 2968374
[TBL] [Abstract][Full Text] [Related]
3. PUVA therapy for polymorphous light eruptions: comparison of systemic methoxsalen and topical trioxsalen regimens and evaluation of local protective mechanisms.
Jansén CT; Karvonen J; Malmiharju T
Acta Derm Venereol; 1982; 62(4):317-20. PubMed ID: 6183864
[TBL] [Abstract][Full Text] [Related]
4. Trioxsalen bath plus UVA effective and safe in the treatment of psoriasis.
Hannuksela M; Karvonen J
Br J Dermatol; 1978 Dec; 99(6):703-7. PubMed ID: 737133
[TBL] [Abstract][Full Text] [Related]
5. Comparison of trioxsalen bath and oral methoxsalen PUVA in psoriasis.
Turjanmaa K; Salo H; Reunala T
Acta Derm Venereol; 1985; 65(1):86-8. PubMed ID: 2578716
[TBL] [Abstract][Full Text] [Related]
6. Trioxsalen bath plus UVA treatment of psoriasis. Plasma concentration of the drug and clinical results.
Salo OP; Lassus A; Taskinen J
Acta Derm Venereol; 1981; 61(6):551-4. PubMed ID: 6177169
[TBL] [Abstract][Full Text] [Related]
7. Biopharmaceutics, pharmacokinetics and pharmacology of psoralens.
Stolk LM; Siddiqui AH
Gen Pharmacol; 1988; 19(5):649-53. PubMed ID: 3063592
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of two dosage forms of oral methoxsalen in psoralens plus ultraviolet A therapy of psoriasis.
Lowe NJ; Urbach F; Bailin P; Weingarten DP
J Am Acad Dermatol; 1987 May; 16(5 Pt 1):994-8. PubMed ID: 3294946
[TBL] [Abstract][Full Text] [Related]
9. Intraindividual and interindividual variability in 8-methoxypsoralen kinetics and effect in psoriatic patients.
Herfst MJ; De Wolff FA
Clin Pharmacol Ther; 1983 Jul; 34(1):117-24. PubMed ID: 6861433
[TBL] [Abstract][Full Text] [Related]
10. Photochemotherapy of psoriasis with methoxsalen and longwave ultraviolet light (PUVA).
Bond CA; Grant K; Boh L
Am J Hosp Pharm; 1981 Jul; 38(7):990-5. PubMed ID: 7020414
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and biopharmaceutic aspects of some psoralen derivatives used in dermatology.
Stolk LM
Pharm Weekbl Sci; 1982 Aug; 4(4):114-5. PubMed ID: 7133962
[No Abstract] [Full Text] [Related]
12. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
[TBL] [Abstract][Full Text] [Related]
13. Influenced of food on the kinetics of 8-methoxypsoralen in serum and suction blister fluid in psoriatic patients.
Herfst MJ; De Wolff FA
Eur J Clin Pharmacol; 1982; 23(1):75-80. PubMed ID: 7128674
[TBL] [Abstract][Full Text] [Related]
14. The effect of methoxsalen dose on ultraviolet-A-induced erythema.
Ibbotson SH; Dawe RS; Farr PM
J Invest Dermatol; 2001 May; 116(5):813-5. PubMed ID: 11348476
[TBL] [Abstract][Full Text] [Related]
15. Spatial distribution of 8-methoxypsoralen penetration into human skin after systemic or topical administration.
Grundmann-Kollmann M; Podda M; Bräutigam L; Hardt-Weinelt K; Ludwig RJ; Geisslinger G; Kaufmann R; Tegeder I
Br J Clin Pharmacol; 2002 Nov; 54(5):535-9. PubMed ID: 12445034
[TBL] [Abstract][Full Text] [Related]
16. Microenema of 8-methoxypsoralen in photochemotherapy of psoriasis.
Siddiqui AH; Stolk L; Korthals Altes-Levij van Vinninghe HR; Kammeijer A; Cormane RH
Arch Dermatol Res; 1982; 273(3-4):219-23. PubMed ID: 7165351
[TBL] [Abstract][Full Text] [Related]
17. Comparison of bioavailability and phototoxicity of two oral preparations of 5-methoxypsoralen.
Stolk LM; Siddiqui AH; Westerhof W; Cormane RH
Br J Dermatol; 1985 Apr; 112(4):469-73. PubMed ID: 3994922
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of a new oral methoxsalen formulation. A serum concentration and photosensitivity response study.
Sullivan TJ; Walter JL; Kouba RF; Maiwald DC
Arch Dermatol; 1986 Jul; 122(7):768-71. PubMed ID: 3729509
[TBL] [Abstract][Full Text] [Related]
19. Topical methoxsalen followed immediately by long-wave UV irradiation. A preliminary report on the treatment of psoriasis.
Danno K; Toda K; Ishida H; Horio T
Arch Dermatol; 1982 Jul; 118(7):471-3. PubMed ID: 7092270
[TBL] [Abstract][Full Text] [Related]
20. Time course of 8-methoxypsoralen concentrations in skin and plasma after topical (bath and cream) and oral administration of 8-methoxypsoralen.
Tegeder I; Bräutigam L; Podda M; Meier S; Kaufmann R; Geisslinger G; Grundmann-Kollmann M
Clin Pharmacol Ther; 2002 Mar; 71(3):153-61. PubMed ID: 11907489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
